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We have isolated a mouse cDNA of 5.4 kb, encoding a new membee of the family of receptor-like protein tyrosine phospkatases, termed mRPTPy. 
The cDNA predicts a protein of 1432 amino acids (not including signal peptide) with a calculated M, of 161 636. In addition, we have cloned the 
human homologue, hRPTPp, which shows 98.7% amino acid identity to mRPTP& The predicted mRPTP# protein consists of a 722 amino acid 
cxtracellular egion, containing 13 potential N-glycosylation sites, a single transmembrane domain and a G88 amino acid intracellular part containing 
2 tandem repeats homologous to the catalytic domains of other tyrosine phosphatases. The N-terminal extracellular pact contains a region of 
about 170 amino acids with no sequence similarities to known proteins, followed by one Q-like domain and 4 fibronectin type III-like domains. 
The intracellular part is unique in that the region between the transmambrane domain and the first catalytic dormain is aboui iii;iz ss large as in 
other receptor-like protein tyrosine phosphatases. RNA blot analysis reveals a single transcript, that is most abundant in lung and present in much 
lower amounts in brain and heart. Transfection of the mRPTPp cDNA into COS cells results in the synthesis of a protein with an apparent M, 
of 195 000, as detected in immunoblots using an antipeptide antibody. The human RPTPp gene is localized on chromosome Ilpter-ql 1, a region 
with frequent abnormalities implicated in human cancer. 
Receptor-like tyrosine phosphatase 
I. INTROIX_JCTION 
Reversible protein phosphorylation has long been 
considered akey mechanism for regulating cellular pro- 
cesses [l]. While the majority of protein phosphoryla- 
tion occurs at serine and threonine residues, phosphory- 
lation at tyrosine residues is attracting a great deal of 
interest since the discovery that many oncogene prod- 
ucts and growth factor receptors posses intrinsic protein 
tyrosine kinase (PTK) activity. The importance of ty- 
rosine phosphorylation in growth factor signal trans- 
duction, cell cycle progression and neoplastic transfor- 
ma.tion is now well established [Z-5]. Tyrosine phospho- 
rylated proteins can be specifically dephosphorylated 
through the action of protein tyrosine phosphatases 
(PTPs) [6-91. Such PTPs are likely to have an equally 
important role as PTKs in the control of cellular growth 
and differentiation and could conceivably be the prod- 
ucts of tumor suppressor genes. The rapidly growing 
family of PTPs can be classified into 2 subgroups : (i) 
cytosolic proteins, in particular PTPlB [lo-143 and the 
T-cell PTP [15], and (ii) transmembrane proteins that 
have structural hallmarks of receptors for extracellular 
signals. Receptor-like PTBs (RPTPs) consist of a cyto- 
plasmic catalytic region, a single transmembrane seg- 
ment and a putative ligand-binding extraccllwlar do- 
main. To date, various cDNAs for RPTPs have been 
isolated, notably for LCA (leukocyte common antigen) 
or CD45 [16], LAR [ 174, PTPc@,E [ 1 g-233 and several 
partial cDNA sequences for putative WPTPs, termed 
PTPyJ, and % [ 18,201. PTPs appear to be conserved 
during evolution, since homologous cDNAs have been 
isolated from Drosophila [24], yeast [25], Cuenorhabditis 
elegans and Styela plicata [I%]. 
Although none of the putative ligands for the 
‘The sequences reported in this paper have been deposited in the have yet been identified, it is widely assumed. that 
EMBL/ GenBank data base under the accession numbers X58287 
(mRPTP,@, X58288 (hRPTPC() and X58289 (mRPTP/?). 
IQPTPs may play a key role in signal transduction and 
growth control. Recent studies with the leukocyte spe- 
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cific RPTP, CD45, provide direct support for that view 
t271. 
111 view of the potential importance of PTPs in nor- 
ma1 and malignant growth, we have used PCR to isolate 
cDNAs encoding n’ew members of the PTP family, as 
a first step in exploring their biochemical and biological 
functions. We report here the molecular cloning of a 
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Fig. I. (A and B) Restriction maps of overlapping human RPTPp cDNA clones (A) and mouse RPTPc( cDNA clones (B). The open reading frame 
is shown as a box. Solid lines indicate the size and order of the various cDNA clones. The broken line indicates the 3’-end containing a poly-A 
tail, found only in one clone (GH65). which has not been sequenced completely. Restriction sites are : PsrI (P), Hind111 (H). &/II (Bg), BunzHI 
(B), and L&RI (E). (C) Model of the mRNA structure of the mRPTPp. Thin lines indicate 5’ and 3’ untranslated regions. Black boxes indicate 
the putative signal peptide, transmembrane segment and both catalytic PTP domains. The hatched regions indicate the Ig-like domain and the 
stippled regions indicate FN type III-like domains. 
new mouse RPTP, designated mRPTPp, encoding a 
transmembrane protein of 1432 amino acids, whose ex- 
tracellular domain shares some structural motifs with 
LAR. In contrast to LAB, however, mRPTPp shows a 
limited tissue distribution, with highest expression in 
lung. En addition, we have cloned the human homo- 
logue of RPTP,u and localized the gene on human chro- 
mosome 18. 
min at 94°C (denaturation), 2 min at 50°C (annealing) and 2 min at 
72°C (extension). Fragments of 300 bp were isolated from a low- 
melting-point agarose gel, digested with EcoRl, subcloned in PGEM- 
3-Zf(-) (Promega) and sequenced. 
2.4. Isolution of RPTPfl cDNA Clones 
2. MATERIALS AND METHODS 
2. I. Materials and General Methods 
Restriction endonucleases and modifying enzymes were purchased 
from Boehringer Mannheim, New England Biolabs, Promega and 
Stratagene. Recombinant Thermus aquaticus (7-09) polymerase was 
from Perkin-Elmer Cetus. Oligonucleotide primers were synthesized 
on a New Brunswick Biosearch DNA synthesizer. Standard DNA 
manipulations and cloning procedures were done according to Sam- 
brook et al. [28]. DNA probes were labeled with [a-3ZPJdATP (Amers- 
ham), using random primed oligonucleotides as primer [29](Boehrin- 
ger Mannheim kit). 
A human Rgt I1 mammary carcinoma cDNA library (Clontech) was 
screened using standard protocols [28] with the purified insert of PCR 
clone14 as probe. cDNA inserts from purified plaques were subcloned 
into PGEM-3-Zf(-) (Promega) and sequenced. The insert of clone 
mcl2 was used to screen a pCD plasmid Hela cDNA library (kindly 
provided by S. Hanks [34J). A random-primed AZAPIt mouse lung 
cDNA library (Stratagene) was screened under reduced stringency 
conditions using the insert of clone pCDPTPc as a probe. High and 
low stringency hybridizations were done under the same conditions 
except for incubation temperatures (hybridization at 42°C or 32°C 
and washings at 65°C or 45”C, respectively). To clone the 5’ coding 
sequence of human RPTPp by PCR, using first strand cDNA prepa- 
red from total Hela RNA, we used 2 oligonucleotides (5’.GGG- 
GATCCATGAGGACACTTGGGACTTG-3’, bp -2-20 and 5’.GC- 
GGGATCCTTCACCTCATCGATAGCG-3’, bp 529-S IO) 
2.5. Nucleotide Sequencing 
2.2, Isofntion of RNA and Northern analysis 
Total RNA was prepared from mouse tissues by the guanidinium 
thiocyanate/CsCI procedure [30]. Total RNA was electrophoresed in 
a 1% agarose gel containing formaldehyde [31] and transferred to 
Hybond N membranes [32]. Baked filters were hybridized at 42°C 
with a 32P-labeled DNA probe (5’ WI-fragment bp 658-1985) for 20 
h as described [33]. 
DNA sequence determination was performed using the Pharmacia 
T7 sequencing kit. To obtain the complete sequence on both strands, 
nested deletion mutants were generated using the Erase-a-base kit 
(Promega) and/or synthetic oligonucleotide primers specific for 
RPTP,IL Sequence data were analyzed using GCG software [35]. 
2.6. Expression of the RPTPp Protein 
2.3. Polymerase Chain Reaction and Subcloning of PTP Domains 
Total RNA from mouse brain was converted to single stranded 
cDNA by oligo(dT) priming and AMV reverse transcriptase. This 
cDNA was used as a template for in vitro amplification with Tag DNA 
polymerase and degenerate primers A (5’.GCGTGAATTCTAC/ 
.rAT’=TT/nGCIACICAG/,GGICC-3’) and B (5’.GGTCGAATTCG- 
GIACICCo/ATGG/ATCIGCrCCA-3’). The PCR was carried out in a 
Perkin-Elmer Cetus thermo-cycler using 30 cycles. The cycles were: 1 
A full-length mouse RPTP,u cDNA was constructed by cloning a 
Hind111 DNA fragment (bp -160-l 372) from clone GH 15 (containing 
the 5’ end, Fig. I b) into the unique Hind111 site (1372) of clone GH4 
(containing the 3’ end, Fig lb). This cDNA was then released as one 
fragment using the Sal1 and XbaI sites in the polylinker and cloned 
into the eukaryotic expression vector pMTZm, resulting in plasmid 
pMT2mFLI. pMT2m was constructed by introducing a polylinker 
using 2 oligonucleotides (5’.AATTCTCTAGACTCGAGGTACCG- 
CGGCCGCCCGGGTCGACCTGCA-3’and S-GGTCGACCCGG- 
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GCGGCCGCGGTACCTCGAGTCTAGAG-3’) between the PsrI 
and the EcoRl restriction site of the pMT2 vector [ZS]. 
A truncated cDNA encoding only the intracellular domain of 
hRPTPp was generated as follows. An oligonucleotide (5’. GCGCTC- 
GAGCCGCCACCATGTTGAAGAAGAGGAAAGTG_3’)contain- 
ing a XhoI restriction site, a start codon, a Kozak consensus sequence 
and bases 2293-2309 of hRPTPy was used together with oligonucleo- 
tide 1330 (5’.CTTAGCCGACTCCCATGG-3’, bp 2757-2740) to am- 
plify 487 bp of the intracellular domain in a PCF? with clone mcl2 as 
template. The amplified product was digested with &/II and XhoI and 
together with a BgflLylrol fragment (bp 24494871) cloned into a 
Bluescript KS vector (Stratagene). A Xlrol fragment of this plasmid, 
containing the intracellular part of human RPTPL( was then subse- 
quently recloned into thepMT2 expression vector resulting in plasmid 
pMT2TR. pMT2TR and pMTfmFL1 were transfected into COS-7 
cells as described [36]. 
2.7. Antibody Preparation 
Rabbits were injected with a synthetic peptide corresponding to the 
predicted C-terminus of the RPTP,u protein (residues 1436-1452) cou- 
pled to bovine serum albumin using the cross-linking agent EDAC 
(I-ethyl-3-(3-dimcthyl-aminopropyl) carbodiimide). Two subsequent 
booster injections were given at t-week intervals with the poptide 
coupled to keyhole lympet hemocyanine. The antiserum was named 
Ab37. 
2.8. Itnnw~olriotling 
Cos-7 cells were cultured in IO cm plates. Two days after transfec- 
tion cells were washed once with PBS (PBS: 137 mM NaCI, 3 mM KCI. 
8.1 mM Na2P04, I.5 mM KHIPO.J, lysed in 4xSDS sample buffer 
(250 mM Tris pH 6.8,8% SDS, 10% v/v glycerol, 100 mM DTT, 0.01% 
w/v Bromophenol blue) and boiled for 5 min. One-tenth of the samples 
was put on 7.5% SDS-PAGE gel. After electrophoresis, proteins were 
transferred to nitrocellulose. Nitrocellulose filters were blocked with 
5% milk powder (Nutricia) in TBST (TBST: IO mM Tris PI-I 8.0, I.5 
mM NaCI, 0.05% Twcen-20, 0.01% BSA). Blots were probed with 1 
to 1000 diluted anti-serum and developed using alkaline phosphatase 
as described 1331. 
2.9. C%romosotnal Localizarion of the ItRPTPp Gene 
For our chromosomal localization studies a panel of well defined 
human-rodent somatic cell hybrids was used [37]. These hybrid lines 
were isolated after fusion of human cells, obtained from different 
donors, with hypoxanthine phosphoribosyl-transferase- or tbymidine 
kinase-deficient rodent cells. Parental and hybrid cells were grown in 
FIO or RPM1 1640 medium supplcmcnted with 2 mlbl glutamine, 100 
U/ml penicillin, 100 p&/ml streptomycin and 10% fetal calf serum. For 
the chromosomal analysis of the hybrid cell lines air-dried chromo- 
some spreads were made according to standard procedures 1371. Of 
each cell line at least I6 metaphascs were examined using R banding 
after heat denaturation. The cells used for chromosomal analysis and 
DNA extraction were always derived from the same culture batch. 
3. RESULTS 
3.1. NeMl Members of the Protein Tyrosine Phosphatase 
(PTP) Family identified by PCR 
In an attempt to identify new members of the PTP 
gene family, we used the following PCR-based protocol. 
Degenerate oligonucleotides were designed correspond- 
ing to conserved regions (amino acids PI IA”/,QGP and 
WPDHGVP) of PTP catalytic domains [38,39]. A first 
round of 30 PCR-cycles was carried out on first strand 
cDNA synthesized from mouse brain RNA. A sample 
(l/50) of this first reaction was reamplified for 25 cycles 
with the same oligonucleotides. The major product of 
this second PCR was a fragment of the expected size of 
300 bp (not shown). Sequence analysis revealed the 
presence of different PTP clones including both catalyt- 
ic domains of LAR, the catalytic domain of the T-cell 
PTP, and two new members af the family, one of which 
appeared to be the putative mouse homologue’ of 
HPTP/? [l S]. The other member (clone PCRl4, Fig. I), 
termed lXPTPp, showed similarities but was not identi- 
cal to previously cloned PTPs. 
3.2. Isolation of RPTPp cDNA Clones 
The 300 basepair insert of clone PCR14 (bp 2902- 
3200 in the final sequence, Fig. 2) was used to isolate 
two cDNA clones (mcl0 and mcl2, Fig. la) from a 
human mammary carcinoma library. One additional 
human cDNA clone (pCDPTPc in Fig. la) of 4.7 kb was 
isolated from a Hela cDNA library. Sequence analysis 
showed that clone pCDPTPc lacked the 5’ end. In an 
effort to obtain a complete RPTPp cDNA, we used the 
entire insert of clone pCDPTPc to screen a mouse lung 
cDNA library. Several overlapping clones were isolated 
(Fig. lb) spanning a stretch of approximately 5.7 kb 
closely corresponding to the size of the mRNA as detec- 
ted in Northern blot analysis (Fig. 5 ; discussed below). 
The 5’ coding sequence of human RPTPp was cloned 
(clones PCM’A-D) from human cDNA by PCIX using 
a primer, starting at the ATG codon, based on the 
corresponding mouse sequence. 
3.3. Analysis of Mouse RPTPp cDAJA Clones 
The cDNA sequence and the deduced amino acid 
sequence of mRPTPp are depicted in Fig. 2. The nucle- 
otide sequence contains a 356 bp 5’ untranslated leader, 
a single open reading frame of 4356 bp encoding a 
polypeptide of 1452 amino acids and a 3’ untranslated 
region. The putative ATG/methionine start codon at 
position 1 agrees well with the described criteria for the 
initiation of translation [4OJ. The deduced amino acid 
sequence shows typical features of a type I transmem- 
brane glycoprotein. The N-terminal 20 residues have all 
of the features of a typical signal peptide [41]. The most 
likely cleavage site is between residues 20 and 2 1. Hence, 
the mature protein contains 1432 amino acids with a 
predicted mass of 161 636. A single transmembrane- 
spanning a-helical segment of 22 hydrophobic residues 
is predicted at amino acids positions 743-764. The puta- 
tive transmembrane domain is followed by a sequence 
of mostly basic residues as is common to the cytoplas- 
mic face of transmembrane domains of many proteins. 
There are 13 potential sites for N-linked glycosylation 
in the extracellular domain (underlined in Fig. 2). The 
predicted intracellular region contains 2 tandemly re- 
peated domains with significant similarity to the catalyt- 
ic domains of previously described PTPs. An alignment 
of the amino acid sequence of the entire intracellular 
region of RPTPp and other PTPs reveals an overall 
identity of 46% to LAR and 3545% to other members. 
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ACGG66ACGGC~ACGGCGK6GKSGGKGClSGGT~~K~lYAGGGlAG~~~YYAGGCGGG~l~Al~AC~G~Y~~CAG~GAGGAlllGGG~YK~G~GGGCG~G~C~TC~G~Y~~C~ 
KT&CGGGTGG~GCCAGAC?Cl~GCGGGGG~CAGGTGG~GGG~AGGAGGAY~KAGGACG~CGlC~C~A~G~~KGG~G~~G~GGGAClYCGGA~Y~GYG~MK~GY~Gl~A~?~YGGG~ 
T~TGGYGTYlGGCYGClGT&G~GTCTACCCTGGKAGCKTGGAGCTTAGGCT&GGGYCYCCCYTGG6TTCCSGMG&YAKCGGCGGCGGKCG~~C~~GCGC~CGGCGKG~A~YGAG~A~C 
AyGAGGACAGYYGG~GTYGCCTGGy~~yYYAGGTGGACY7VyGCTMCTGCGG~CGGAGAAACATTTYGAGGVGG&TGC616TTVG~~~~ATA~AGEACAVGI 
~RyLGlCLVYLAGLLLTA~AGElFSGGGLF~EPYSy~G~SQ 
GCTW\CGAAC~YGA~TTC~GYGGGAGCA~GTGAACACCCTGAC&AIVI~~~A~~~~C~GGATGC~AY~AGGAICCCAVCAG~~GGYCAA~ACY~CYGG~RAACGAGMG~C~AG 
AD E D D F NW E PV WTLTK P y SD P WH P 8 0.5 F r( L V WA G Y P E GQ 
AGAGCTCACCYGClC6yGEGTGAGCVVAAGWIRAAVOICA~C~A6TG6AY6GASTYTCAGYACYVYGlAT6CAGCbAGAGTAA~GCTGGTCGTGGG7TGGTGMTGTCTATG~G~GGyG 
RAHLLL.I’f3LKE#_&_JH&IDFHYFVSsKs~AAPGLLNVYVKV 
MTMlGGAGCACYGGGGMY~CCAlGyG~CAYAY~~G~~C~~~A~~~G~A~GlGGCACAGGG~A~GGTGGCCAY~GGA%GyY~VGGG~~~~lTyyACCAGGYGAyy~yyGM 
NNGPLGNPlU~GQPTRTYHRAELAISTFUPUrYOVlfE 
GyGGltACCYCTGG66AT~GG~lAG~YYG~yAl~~l~GyY~GGY6yyAGGACAC66GTG6A~R~~y~~~~A~llG~~G~G~llGAIGAAGGTGGLIGGTGAAlG~CGGGCAO 
VVYsGH‘3GYLAIDEVKVLGHPCTRYF’HFLRlQUVEVNAGQ 
VyyG~yA~CYl~CAGlGCAGGGG%ATAGGCAGGAeAeTGt~CGGGlC?GGGTGCAGGGAATyGAyGyC~GAWITGGCCCYC~~G~~~~GGl~~~AGYTCCA~GA 
FAyFPCGAIGRTVAGDRLMLQGIDVKQAPLKE~KVlSS~R 
T?CATAG&GTGAVlyAA~GTTGyRAR~A~GACCAAI;AGAb;RCtCTGGGMGyACCGC?GCA~G~Y~TGCAK~~GGAGGYGl6GGW\lA~CAAACTA~GCAGIUTTGG~A~~~~~~S 
FIA5FNVVU?VKR~AGKYRCHlt;;GEVGISUYAELVVLE 
&~AC~YGTTCCCAY~G~CGCA661CAGCTCGCGTGTGYGGGACCAACGTAYCYGYGGAlACAGCTCMTG66MCYC~AY~M~GGGGACG~CCCA??GlGG~~~GKGAGG~Y~GYAC 
PPVPtAPPOLASVGATYLWlQLNANsINGDGPIVAREVEY 
yGEA~AG~GAGGGG6AGCVG~Y~y~GGCAG66AGYGtAT?CCACGAGVyACAAGAYTGGG~ACCTYGA66CAGACACAGAGlA?GAGAT~AGlGyG~llGYTA66AGAC&AGGAWIA 
CTA§G5UNDROPVD5ysYKIGtfLDPDlEYEISVLLTRPGE 
GG6GG6A6yGGGY~lG66GGG~CAG~?~YGA~CMGGA~~GYGyGC~GAl~~~AlGCGlGGCCCGAG~~TA~G~YGTGGAGGy&~?CTCGAGAY~A~~Al66G~TGG 
GGTGSP6PALRYRYKGADPW~G~~KLGVVEVKS~Q~YlR~ 
CAGCGGTlyGGAlACAATGT~C~~GyTG~~A~AGTTAY~l~Y~A~AGlGCA~TA~GGyYACCAGGy~GGAGGGCAGGAG~AGGyG~GAGMG~GyGAG~lGGGAYA~AGAY~~Y~~ 
EPFGYYVTRGH§YNLYVHVGYQVGGOEOVREEVsU~lDNs 
CAGCGlCAGGACACC~~GlG~~G~~GYACACC~~Gl~AG~G~GAAGClYAY~~lGAlG~~~~GGAGGG~CGC~GG~G~~~~~y~ACGGlG~A~~GGAlGAA~~ 
HP 0 H Y ITY L 8 P Y YolyDV KLIL H N P E G R K E S Q E L 1’4’3 T D ED 
CTCC~AGGAGCYGY~&CCACTGAAVGCAVCGMGGKAGyGCC~TlGAAGAGAAGATATTlCYYCAGTGGAGAGAGC~GACAC~~AYAyGGGGlCAy~A~~YVAYAT~WITCA~CyAC 
LPGAVPlEslPGSAFEEKlFLQWREPlQyYGVlTLYElTY 
AI\I\G6AGY&AGYYCCTYT~C~~GG~lAGAY?lAl~~M~~~GYGGG~GAGllTC~AA~lGGGA~y~~G~A~YY~~yG~l~?llG~C~TGlAY~~TG~~~~G?AClCG 
KAVS§FDPEIDLSYQSGRVsKLGHE?WFLFFGLYPGlYYs 
YyCACCATGAGAGCcAGGACAGCGMGGGG?Y~GGA~~y~~AAACCAGTTCACCACAAAAAyAYCAGCACCAICCAlGECAGKGTAiGMITYGAGACACCTTyGAAY~AGACT 
FTIRA§YAKGFGPPA?UQFTyK~SAPSHPAYEFETPlUQT 
GATAAYACAGyGA~yGyGAyG~YG~~~lG~A~AAAG~AGAGGGGCy~~AGlCAGlGlCTAT~MAY~GYYGlyGAGGAAGAA~Gl~~T~GGAG~Cl~G~GA~~~AGAGAl~TlG 
DN?VIVWLKPAQSRGAPV4VYQlVVEEERPRRyKKlTElL 
MGTGTlA~CCSGyGCC~y~GACYTCCAGAATGCGYCCAYCCTGAAG~CACAGTACTACTYyGCyGCAGAAlYYC~?GCAGACAGCGyG%MGCyGClG~~~AyTYACCATYGGTCAG 
KCYPVPIHFPNASlLNSQYYFAAEFPAB§lQAAQPF~~GD 
AA?AAGAGAYACAAICGGVA~YGGM~A~~~~~~y~~YC~~~CAyAMAGCTACAGAA??yATyACCAAGCYGCTAGTCGAGCCAAYGGGGAAACC~yyGAGTGYGY~~~G~GGCC 
NKYYNCYWNTPLLF’HKSYR~YYQAASRANGEYK~DCVRVA 
~GGGC~G~~AS~~C~GCCTG~C~~~G~C~YGAG~~~A~AGA~C~~A~GG~~~~~~G~~GGAG~GA~~GC~GGC~~~~~G~TGTTTG~~A~~A~ATTTG~~GG~G~~ 
TKGAVTPKPVPEPEYQTDHTVK 
GyGCyGGyGAlGRAGAAGAG~~yGG~~M~GAGG~GGAGA~GAyGAGCAG~A~~~GG~AG 
KRKLAKKRYETHSSTRQ 
~CTYCTCF1yGAYGGGGACG%A~My&~PAATGGGAGAY~lGyGYCCYCGCCATCAyCCTlYACGA?~GAI1ACACGCfeAGCACA?CGGTGCGGRA?yCCTAT 
NCD&AFSFWGyWNl.NGR SV5SPSSFTWKyNTLsYSVPNSY 
TA6CCAGA?GAGAG&CACA~AAV&GeeAOT(jAGA66AOCAG~~yGSCA~AG~K~~AyA~~TAYAAGAAA~GCGAGGCGGCAGA~GYG~CY?A~~AGA~yGGGCAG~ll~A~~~GGCCAlC 
Fig. 2. cDNA nucleotide and its deduced amino acid sequence of mRPTPp. The putative signal peptide and transmembrane region are heavily 
underlined, Potential N-linked glycosylation sites (N-X?/T) are underlined, Both PTP domains are indicated with a shaded back- 
ground. 
The intracellular part of RPTPp shows an unique fea- 
ture among the known RPTPs in that the cytoplasmic 
stretch linking the transmembrane segment to the first 
126 
catalytic domain is about 70 residues iarger than in any 
other RPTP identified to date (158 versus 77-90 amino 
acids). This region is relatively rich in serine and threo- 
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intracellular 
Fig. 3. Schematic comparison of scvcral members of the RPTP family. 
Ig-like domains arc repecscnted by characteristic disulphide-linked 
structures. The small black boxes represent FN type III-like domains 
and the large open boxes represent the PTP domains. ‘aa’ denotes 
‘amino acids’. DLAR, Drosophila EAR homologue, DPTP, Droso- 
phila PTP (for reference see [ 17,18,24]). 
nine residues (20%), making regulatory phosphoryla- 
tion a possibility. 
The extracellular region of RPTPp contains one Ig- 
like domain and 4 fibronectin (FN) type Ill-like do- 
mains. These structural motifs have previously been 
identified in EAR, HPTP/I, HPTPG and in several other 
cell-surface molecules, such as the cell-adhesion mole- 
cule N-CAM [42] and the product of the tumor suppres- 
sor gene, DCC 1431, In addition to these motifs, the N- 
terminus of the predicted RPTP,u protein contains a 
stretch of 170 amino acids (residues 2 I-196) that shows 
no significant similarity to known sequences in the 
EIMBE and GenBank databases. The deduced structure 
of the RPTP@ protein, as compared to that of several 
related RPTPs, is schematically shown in Fig. 3. 
3.4. Analysis of’Hu~?~n RPTl’p cDN.4 Clones 
The human RPTP,.# cDNA sequence shows 88.5% bp 
identity to the mouse sequence. A comparison between 
both amino acid sequences is illustrated in Fig. 4. It is 
seen that mRPTP~ and hRPTPp differ by only 37 
amino acids, i.e. 98.7% sequence identity at the amino 
acid level. 
3.5. Distribution of’tlze Mouse RPTPp &WA 
High stringency Northern analysis of total RNA of 
WRTLGTCLVY LAGLLLTMG PYFSGGCLFD EPY5yCGYSQ RDEDDFNUEP 50 
..,---..A, .,....,,,- -,_,---,.- ,.,,,,,.,- .car.,-..,,- 
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.,,..-,.,- ____.._L__ __A,,R_,__ ,.--,_,.-- ,.,,-.,,,. 
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.,,..-“.Sp _....,.___ -,_...,,.- ,.,.._..-- R,_,,,,,,, 
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GLNAYSIWGO GPIVAREVEY CTASGSWUIIR OPVDSYBYKI GHLDFOYEYE 350 
,,,,,-,,,, ,,,-...-,. . . . . . . . . . . ..--...... .,,.,,.,.. 
..Y.“.. . 
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k,mam ..,,,-.-., ,,,,...... .,_,-,,.., .,-,....-, ..-,, *.,,. ..-.-. 
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Fig. 4. Alignment of the mouse and human RPTPp amino acid sc- 
quences. Identical amino acids are shown with a dashed line. 
various mouse tissues, using an extracellular cDNA 
probe, reveals a single transcript of approximately 5.7 
kb in lung and, at much lower levels, in brain and heart 
(Fig. 3). The size of the cloned cDNA is in good agree- 
ment with this transcript size. 
3.6. Transient Expression of the RPTPp Protein 
While the cDNA sequence predicts a mature polypep- 
tide of M, 162 000, the apparent size of the expressed 
protein remains to be determined. We therefore trans- 
fected the mRPTPp cDNA into CQS-7 cells and after 
48 h cell extracts were analyzed by immunoblotting, 
using antiserum Ab37 raised against a C-terminal pep- 
tide of 17 amino acids. As shown in Fig. 6 (lane 3), the 
antiserum recognizes a single protein of apparent 1M, 
195 kDa. Since the predicted size of the peptide back- 
bone is about 162 kDa, the mature protein is likely to 
be glycosylated at many of the 13 putative N-glycosyla- 
tion sites. We also transfected a truncated hRPTPp 
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cDNA, lacking the external region, into GOS cells (see 
section 2). In this case, a protein of the predicted molec- 
ular mass of 80 kBa was expressed (Fig. 6, lane 2). 
3.7. Chromosomai Localization of the Human RPTPp 
Gene 
To determine the chromosomal localization of the 
human RPTP,u gene, an extracellular domain cDNA 
probe (bp 333-1985) was hybridized to a panel of 19 
human-mouse or human-hamster cell lines containing 
various subsets of human chromosomes (Table I). From 
these hybridization results it is clear that the ~RPTP,!J 
gene must reside on chromosome 18. All cell lines con- 
taining chromosome 18 were scored positive for 
hRPTPp. whereas all (except one) of the lines lacking 
this chromosome were negative. In one cell line a #18 
rearrangement may have occurred after cell fusion 
resulting in lack of cytogenetic detection. For all other 
human chromosomes discordancy scores were invaria- 
bly higher. In order to further refine RPTP,u gene local- 
ization, a hybrid cell line, obtained after fusion of 
t(X;l8)(pl I ;qll) synovial sarcoma cells with a hamster 
cell line, containing the der(X) chromosome, was used. 
This line was negative for hRPTPp which implies that 
hRPTPp is located in the region IBpter-qll. 
4. DISCUSSlOW 
In this paper we describe the isolation and characteri- 
zation of a cDNA encoding a novel receptor-like pro- 
tein tyrosine phosphatase, RPTP,u. Since the first purifi- 
cation and sequencing of a cytosolic PTP by Tonks et 
al. [lO,l 11, the number of cloned PTP cDNAs has in- 
creased steadily (for overview see [44,45]). The multi- 
gene nature of the PTP family suggests that these en- 
zymes may act on distinct cellular substrates and that 
they are differentially regulated. In vitro studies have 
already indicated that different members of the family 
show different affinities for artificial substrates [181, but 
our understanding of the function and regulation of 
these enzymes is still in its infancy. Most of the newly 
identified PTPs have a receptor-like structure, strongly 
suggesting that these proteins act by transducing ex- 
tracellular signals into the cell interior. The great di- 
versity of their extracellular regions, varying between 27 
and 1599 amino acids in length [44], suggests that there 
might be many different ligands regulating the activities 
of these enzymes. Although the nature of these ext’racel- 
iular signals is still unknown, studies with CD45, a leu- 
kocyte-specific RPTP, suggest a key role in signal 
transduction and growth control for RPTPs in general 
(for review see [46]). CD45, the best characterized RPTP 
at present, has a critical role in T-cell activation and 
proliferation. CD45 is thought to activate a src-like 
PTK, p561ck, by dephosphorylation of a regulatory 
phosphotyrosine residue [47-501. T cell clones lacking 
expression of CD45 are incapable of generating phos- 
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phoinositide-derived second messengers and fail to pro- 
liferate in response to T-cell receptor activation [27]. 
While the expression of CD45 is limited to cells of the 
hematopoetic lineage, other RPTPs, such as PTPa [19] 
and EAR [17], have a much wider tissue distribution, 
suggestive of a more general role. Expression of 
mRPTPp is predominantly observed in lung, brain and 
heart, with little or no expression in other tissues, sug- 
gesting that its function may be restricted to certain cell 
types.The extracellular part of several RPTP,& in com- 
mon with that of LAR :>nd a few other RPTPs, bears 
some structural similaritics (Ig-like and FN type III-like 
domains) to cell-adhesion molecules, such as N-CAM. 
Although the functional significance of these common 
structural motifs is not yet clear, it has led to the widely 
discussed hypothesis that RPTPs may serve a function 
in cell-cell and/or cell-extracellular matrix interactions. 
On the other hand, it should be realized that Ig-like and 
FN type III-like domains are also found in receptors for 
soluble ligands [51], making conjectures about the na- 
ture of the ligand somewhat premature. 
The great variety observed among the extracellular 
Table I 
Relationship between the prescncc of human chromosomes and 
human R-PTP,u in I9 human rodent somatic cell hybrid clones 
Human 
Chromo- 
some 
Chromosome/R-PTPfl* Disc- 
+I+ +/- -/- 
ordancy** 
-/+ 
1 8 
2 6 
3 7 
4 9 
5 9 
6 5 
7 6 
8 8 
9 5 
IO 4 
II 7 
I2 6 
I3 5 
14 7 
I5 7 
I6 IO 
I7 I7 
I8 IO 
I9 7 
20 IO 
21 IO 
22 7 
X 8 
3 3 5 32 
0 5 8 26 
2 4 6 32 
3 2 5 26 
3 2 5 26 
4 6 4 53 
3 S 5 42 
5 3 3 42 
3 6 5 47 
4 7 4 58 
4 4 4 42 
4 S 4 47 
2 6 6 42 
3 4 5 37 
4 4 4 42 
4 I 4 26 
7 4 I 58 
0 I”’ 8 S 
5 4 3 47 
4 I 4 26 
2 I 6 16 
4 4 4 42 
7 3 I 53 
*Presence is indicated by 4, absence is indicated by -. 
**Calculated as (+‘-) + (-‘+) x 100% 
***In one clone chrokome I8 was not observed via cytogcnctic 
analysis. This may due to translocation r rearrangcmcnt after cell 
fusion. 
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(a) 
Fig. 5. Northern blot analysis of the mouse RPTPp mRNA. Total 
RNA (I 5 &g per lane) prepared from the indicated mouse tissues was 
used for Northern blotting. The blot was hybridized with a cDNA 
probe coding for part of the extracellular domain of mRPTPp. (A) 36 
h exposure (using 2 intensifying screens). (B) 7 day exposure (using 2 
intensifying screens). 
regions of the RPTPs is in marked contrast to the con- 
servation of the intracellular catalytic domains. Pt re- 
mains to be investigated whether the various catalytic 
domains of RPTPs have distinct substrate specificities 
involving specific PTKs, their tyrosine phosphorylated 
substrates, or both. Knowledge of the RPTPfl primary 
sequence should now permit delineation of its biochemi- 
cal and biological activities and elucidation of its pre- 
sumed role in signal transduction. 
The possibility that PTPs may function as tumor- 
suppressor genes is consistent with current knowledge 
about mechanisms of cellular growth control. Direct 
evidence for this notion comes from a recent study 
showing that the gene for PTPy, a partially cloned 
RPTP, has characteristics of a candidate tumor sup- 
pressor gene at human chromosome 3~21 1521. Our 
results indicate that the human RPTP,u gene maps to 
chromosome 18, region pter-ql 1. This region is of par- 
ticular interest since cytogenetic aberrations within this 
region are frequently encountered in various neoplastic 
disorders, particularly colon carcinoma [53], synovial 
carcinoma [54] and malignant lymphoma [55]. In situ 
hybridization studies using a genomic clone are in pro- 
gress to further refine the determination of the chro- 
September 1991 
1 2 3 
Fig. 6: Immunoblot analysis of the RPTPp protein. Transiently trans- 
fected COS cells were analyzed for RPTPp expression as described in 
section 2. Lane 1, lysates of cells tranfected with vector pMT2m 
without insert. Lane 2, lysates of cells transfected with pMT2TR 
containing a truncated form of the hRPTPp cDNA. Lane 3. lysates 
of cells transfected with pMT2mFL containing a full length mRPTPp 
cDNA. Sizes of molecular mass markers are shown in kDa. 
mosomal locus of the RPTPp gene. Knowledge of the 
precise chromosome locus, along with comparative stu- 
dies in normal and malignant cells, may help to esta- 
blish whether KPTPp can function as a growth sup- 
pressor and may play a role in tumorigenesis. 
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